Sign in Subscribe
Cancer research

Prostate Cancer Research Uncovers New Insights into Radiotherapy Impact

Strategic Insights

— 1 min read

A recent study has shed new light on the effect of radiotherapy on prostate cancer patients, particularly in regards to dose-response mapping (DRM) and its impact on identifying high-risk subregions in the bladder and rectum.

Key Takeaways:

  • The study analyzed 1808 datasets from prostate cancer patients undergoing radiotherapy, with 589 exclusions before toxicity-specific data removal.
  • Baseline toxicity correction increased event counts for urinary tract obstruction, retention, urgency, and incontinence by 82, 82, 286, and 226, respectively, when compared to without baseline correction.
  • The research found that DRM without baseline correction appears more sensitive to high-risk subregions due to higher event counts.
  • However, no significant associations between rectal DSMs and rectum-related toxicities were found.
  • The study suggested that non-linear toxicity grading and multivariable analysis may enhance DRM reliability.
  • The research was conducted by investigators from Fondazione IRCCS Istituto Nazionale dei Tumori, in collaboration with researchers from other institutions.

Statistics:

  • 1808 datasets analyzed from prostate cancer patients undergoing radiotherapy
  • 589 exclusions before toxicity-specific data removal
  • 82, 82, 286, and 226 event counts increased for urinary tract obstruction, retention, urgency, and incontinence with baseline toxicity correction
  • 93, 104, 465, and 361 event counts without baseline correction
  • 1143, 186, 1768, 1848, 516, 0, and 33/0 significant voxels for urinary incontinence, obstruction, retention, and urgency in bladder DSMs with/without baseline correction
  • 604, 0, 1980, 889 significant voxels for urinary incontinence and tract obstruction in rectum DSMs with/without baseline correction

Sources:

  • NewsRx. Research Findings from Fondazione IRCCS Istituto Nazionale dei Tumori Update Understanding of Prostate Cancer (Dose-response mapping of bladder and rectum in prostate cancer patients undergoing radiotherapy with and without baseline toxicity correction). Health & Medicine Week. July 25, 2025; p 3649.
  • Dose-response mapping of bladder and rectum in prostate cancer patients undergoing radiotherapy with and without baseline toxicity correction. Physics and Imaging in Radiation Oncology, 2025,35():100805. (Physics and Imaging in Radiation Oncology - https://www.journals.elsevier.com/physics-and-imaging-in-radiation-oncology/)
  • https://doi-org.sdpl.idm.oclc.org/10.1016/j.phro.2025.100805

Read more